ZTZ-22305-88700
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 600 / IL
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Moderna
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-16
-
2021-02-17
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · Headache, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-27
-
2021-03-04
Survey response — day 21, dose 1MedDRA: Cough, Fatigue, Oropharyngeal pain — Feeling: FairFree text: Fatigue, sore throat, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Dose 2 — Moderna
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-14
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-06-10
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: FairFree text: Heavy menstrual bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-09
Survey response — 6 months, dose 2MedDRA: Adnexa uteri pain, Heavy menstrual bleeding, Pregnancy test false positive, Smear cervix abnormal — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: New and worsening gynecological symptoms - ovary pain, increased bleeding, abnormal pap, false positive urine pregnancy testMedDRA releases: 2024-11 · check-in free text available
-
2021-09-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Moderna | |
| 2 | 2021-03-11 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-09 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 5 — day 21, dose 1
Symptoms: Fatigue, sore throat, cough
Release 9 — 3 months, dose 2
Symptoms: Heavy menstrual bleeding
Release 9 — 6 months, dose 2
Symptoms: New and worsening gynecological symptoms - ovary pain, increased bleeding, abnormal pap, false positive urine pregnancy test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adnexa uteri pain | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy test false positive | · | · | ✓ |
| SD | Smear cervix abnormal | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release